BANK OF AMERICA CORP /DE/
BankPosition in CAPR — Capricor Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in CAPR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,049,738
-$6,580,945 QoQ
Shares Held
251,235
-39.5% QoQ
Ownership
0.432%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 169 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CAPR Over Time
Shares Held
Position Value (USD)
Derivatives in CAPR
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$993
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. CAPR ranks #132 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in CAPR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,049,738 | 251,235 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,630,683 | 415,483 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,553,215 | 53,819 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $993 | 100 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $682,677 | 68,749 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,044,430 | 110,056 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,353,492 | 170,543 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $249,687 | 16,416 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $78,880 | 16,537 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $149,392 | 22,002 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $116,028 | 23,728 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $50,407 | 14,739 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $41,796 | 8,744 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,908 | 1,400 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $111 | 29 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $21,000 | 3,500 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $17,450 | 5,000 | Shares | Defined | 2022-08-12 | |
| 2021-09-30 | $1,354 | 337 | Shares | Defined | 2021-11-15 | |
| 2020-06-30 | $59 | 13 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $300 | 250 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||